What is Acrodermatitis Enteropathica

Acrodermatitis enteropathica is a rare genetic disorder characterized by the body's inability to properly absorb zinc from the diet, leading to severe deficiency. If left untreated, Acrodermatitis enteropathica causes a distinctive triad of symptoms: skin rashes (dermatitis), hair loss (alopecia), and chronic diarrhea.

What causes Acrodermatitis enteropathica?

The underlying mechanism of Acrodermatitis enteropathica involves a mutation in the SLC39A4 gene. This gene is responsible for creating a protein that acts as a "gatekeeper" for zinc absorption in the small intestine. When this protein is dysfunctional, the body cannot absorb enough zinc, even if the patient's diet contains adequate amounts, leading to the clinical manifestations of Acrodermatitis enteropathica.

Who is affected by Acrodermatitis enteropathica?

Acrodermatitis enteropathica is extremely rare, with an estimated prevalence of approximately 1 in 500,000 people. It is an autosomal recessive condition, meaning an individual must inherit a mutated gene from both parents to develop the disease. Symptoms typically appear in early infancy, often shortly after a baby is weaned from breast milk to formula, as breast milk contains factors that temporarily aid in zinc absorption.

What are the primary clinical signs?

The physical presentation of Acrodermatitis enteropathica is often striking and helps differentiate it from other inflammatory skin conditions. Common symptoms include:

• Periorificial dermatitis (red, scaly rashes around the mouth, eyes, and anus).


• Alopecia (patchy or total hair loss).


• Chronic, persistent diarrhea.


• Paronychia (inflammation of the nail folds) and nail dystrophy.


• Irritability and delayed growth in children.

How is Acrodermatitis enteropathica distinguished from other conditions?

Unlike transient zinc deficiency caused by dietary insufficiency or malabsorption syndromes, Acrodermatitis enteropathica is a specific genetic defect. It is often misdiagnosed as severe diaper rash, psoriasis, or eczema. A key diagnostic marker is the rapid and dramatic improvement of symptoms once high-dose oral zinc supplementation is initiated under medical supervision.

Next steps

• Consult a pediatric dermatologist or a metabolic specialist to confirm the diagnosis through genetic testing and serum zinc levels.


• Connect with the 1 member currently registered on DiseaseMaps.org to share experiences and coping strategies.


• Maintain strict adherence to prescribed zinc supplementation, as this is a lifelong requirement for managing Acrodermatitis enteropathica.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Acrodermatitis Enteropathica.


• Orphanet: Rare Disease Database (ORPHA:1062).


• OMIM (Online Mendelian Inheritance in Man): Entry #201100.


• PubMed/NCBI: Clinical literature on SLC39A4 gene mutations and zinc transport.